| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 24.98B | 25.11B | 23.18B | 21.31B | 19.19B | 16.74B |
| Gross Profit | 14.46B | 15.65B | 14.76B | 13.99B | 12.99B | 11.42B |
| EBITDA | 1.03B | 1.40B | 3.27B | 3.35B | 4.21B | 3.47B |
| Net Income | -669.47M | -461.80M | 1.27B | 1.42B | 2.14B | 1.66B |
Balance Sheet | ||||||
| Total Assets | 32.22B | 33.83B | 31.49B | 29.43B | 27.34B | 25.19B |
| Cash, Cash Equivalents and Short-Term Investments | 2.35B | 3.18B | 2.32B | 2.80B | 2.59B | 2.47B |
| Total Debt | 4.31B | 3.29B | 1.49B | 1.87B | 1.85B | 3.09B |
| Total Liabilities | 8.25B | 9.09B | 5.88B | 6.14B | 5.85B | 6.48B |
| Stockholders Equity | 23.96B | 24.68B | 25.51B | 23.16B | 21.39B | 18.63B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -504.10M | 302.45M | 870.67M | 1.53B | 1.23B |
| Operating Cash Flow | 0.00 | 1.05B | 2.10B | 2.19B | 3.11B | 2.60B |
| Investing Cash Flow | 0.00 | -1.67B | -1.80B | -1.48B | -1.75B | -1.35B |
| Financing Cash Flow | 0.00 | 1.49B | -840.71M | -514.78M | -1.29B | -1.31B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥20.32B | 15.12 | ― | 3.02% | -4.36% | -14.92% | |
68 Neutral | ¥97.03B | 26.70 | ― | 2.31% | 4.36% | 79.43% | |
65 Neutral | ¥252.17B | 36.37 | ― | 1.92% | 4.31% | 96.31% | |
63 Neutral | ¥15.20B | 14.76 | ― | 3.12% | 3.59% | -163.08% | |
56 Neutral | ¥65.24B | 87.82 | -0.46% | ― | -4.30% | 82.87% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
51 Neutral | ¥142.06B | 28.05 | 2.42% | 3.73% | 0.04% | ― |